Current Pharmaceutical Design
Title:Editorial: [Hot Topic: Bio-Pharmaceutics and Materials in Oral Cavity]
Volume: 18 Issue: 34
Author(s): Giuseppina Campisi
Affiliation:
Export Options
About this article
Cite this article as:
Campisi Giuseppina, Editorial: [Hot Topic: Bio-Pharmaceutics and Materials in Oral Cavity], Current Pharmaceutical Design 2012; 18 (34) . https://dx.doi.org/10.2174/138161212803307455
DOI https://dx.doi.org/10.2174/138161212803307455 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
20
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress
Anti-Cancer Agents in Medicinal Chemistry A Prooxidant Mechanism for the Anticancer and Chemopreventive Properties of Plant Polyphenols
Current Drug Targets Minimally Invasive Transoral Surgical Treatment for Oropharyngeal Carcinoma
Current Cancer Therapy Reviews Radiation Protection of the Child from Diagnostic Imaging
Current Pediatric Reviews Characteristic Alterations of Nuclear Structure and Chromatin Organisation of Cancer Cells Addressed by Proteome Analysis**
Current Proteomics Investigating the Molecular Basis of Drug Action and Response: Chemocentric Genomics and Proteomics
Current Drug Targets From Hygiene Hypothesis to Novel Allergic Asthma Therapeutics
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Probiotics: From Functional Foods to Pharmaceutical Products
Current Pharmaceutical Biotechnology Upfront DPD Deficiency Detection to Secure 5-FU Administration: Part 2- Application to Head-and-Neck Cancer Patients
Clinical Cancer Drugs Glucans as Biological Response Modifiers
Endocrine, Metabolic & Immune Disorders - Drug Targets An Environmentally-Benign Synthesis of Spiro-benzo[1,4]diazepines Using Multi Phase Nano-titania as a Highly Efficient Catalyst via MAOS Technique
Current Organic Synthesis microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design Antiangiogenic Therapy
Current Pharmaceutical Design Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
Current Drug Targets Endoglin-Targeted Cancer Therapy
Current Drug Delivery SDH Genes: From Glomic Tumours to Pheochromocytomas
Current Hypertension Reviews Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy
Current Cancer Drug Targets Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets
CNS & Neurological Disorders - Drug Targets Advances in Interleukin-12 Gene Therapy for Acquired Liver Diseases
Current Gene Therapy Biological Interfacial Engineering for Metastatic Cancer Diagnosis and Intervention
Current Medicinal Chemistry